Literature DB >> 24438732

Obesity and the obesity paradox in heart failure.

Adrienne L Clark1, Gregg C Fonarow2, Tamara B Horwich3.   

Abstract

Obesity is a growing public health problem in the general population, and significantly increases the risk for the development of new-onset heart failure (HF). However, in the setting of chronic HF, overweight and mild to moderate obesity is associated with substantially improved survival compared to normal-weight patients. Evidence exists for an "obesity paradox" in HF, with the majority of data measuring obesity by body mass index, but also across various less-frequently used measures of body fat (BF) and body composition including waist circumference, waist-hip ratio, skinfold estimates of percent BF, and bioelectrical impedance analysis of body composition. Other emerging areas of investigation such as the relationship of the obesity paradox to cardiorespiratory fitness are also discussed. Finally, this review explores various explanations for the obesity paradox, and summarizes the current evidence for intentional weight loss treatments for HF in context.
© 2014.

Entities:  

Keywords:  BF; BIA; BMI; Body mass index; CRF; DEXA; EATE; HF; Heart failure; Obesity paradox; WC; Waist circumference; bioelectrical impedance analysis; body fat; body mass index; cardiorespiratory fitness; dual-energy x-ray absorptiometry; heart failure; picardial adipose tissue; waist circumference

Mesh:

Year:  2013        PMID: 24438732     DOI: 10.1016/j.pcad.2013.10.004

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  43 in total

Review 1.  Obesity Interventions for Older Adults: Diet as a Determinant of Physical Function.

Authors:  Connie W Bales; Kathryn N Porter Starr
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

Review 2.  Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy.

Authors:  Ambarish Pandey; Jarett D Berry; Carl J Lavie
Journal:  Curr Heart Fail Rep       Date:  2015-10

Review 3.  Healthy obese versus unhealthy lean: the obesity paradox.

Authors:  Carl J Lavie; Alban De Schutter; Richard V Milani
Journal:  Nat Rev Endocrinol       Date:  2014-09-30       Impact factor: 43.330

4.  Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry.

Authors:  Tiffany M Powell-Wiley; Julius Ngwa; Selomie Kebede; Di Lu; Phillip J Schulte; Deepak L Bhatt; Clyde Yancy; Gregg C Fonarow; Michelle A Albert
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

5.  Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Erica Billig; Kaleb Michaud; Said Ibrahim; Liron Caplan; Grant W Cannon; Andrew Stokes; Vikas Majithia; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

Review 6.  Weight loss and physical activity for disease prevention in obese older adults: an important role for lifestyle management.

Authors:  Willy Marcos Valencia; Mark Stoutenberg; Hermes Florez
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

Review 7.  Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

Authors:  Abdullah Kaplan; Emna Abidi; Ahmed El-Yazbi; Ali Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

8.  The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study.

Authors:  Arun Krishnamoorthy; Melissa A Greiner; Alain G Bertoni; Zubin J Eapen; Emily C O'Brien; Lesley H Curtis; Adrian F Hernandez; Robert J Mentz
Journal:  J Card Fail       Date:  2016-03-11       Impact factor: 5.712

Review 9.  The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care.

Authors:  Michael D George; Joshua F Baker
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

10.  Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Authors:  G Youcef; A Olivier; N Nicot; A Muller; C Deng; C Labat; R Fay; R-M Rodriguez-Guéant; C Leroy; F Jaisser; F Zannad; P Lacolley; L Vallar; A Pizard
Journal:  Br J Pharmacol       Date:  2016-04-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.